Regeneron Pharmaceuticals Inc (REGN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 14.234 | 15.231 | 23.849 | 15.944 | 21.979 | 37.914 | 15.877 | 12.693 |
Return on Equity (%) | 22.101 | 22.628 | 32.808 | 21.321 | 31.772 | 54.207 | 20.942 | 16.258 |
Return on Invested Capital (%) | 29.838 | 30.494 | 42.064 | 26.677 | 38.453 | 69.274 | 28.802 | 20.938 |
Operating Margin (%) | 27.508 | 35.823 | 38.471 | 31.275 | 45.513 | 58.383 | 40.403 | 32.57 |
Net Profit Margin (%) | 18.425 | 20.41 | 36.425 | 26.907 | 41.346 | 50.245 | 35.64 | 30.141 |
Book Value Per Share | 20.756 | 27.292 | 38.352 | 49.752 | 50.984 | 85.431 | 98.167 | 113.215 |
Earnings Per Share | 4.178 | 5.324 | 10.705 | 9.492 | 16.246 | 36.757 | 19.582 | 17.951 |
Cash Per Share | 2.497 | 3.61 | 6.428 | 7.258 | 10.144 | 13.135 | 14.019 | 12.396 |
Working Capital Per Share | 9.044 | 14.212 | 21.918 | 25.09 | 32.748 | 45.893 | 57.517 | 72.901 |
Operating Profit Per Share | 21.764 | 24.952 | 28.12 | 32.689 | 36.478 | 63.547 | 49.849 | 53.235 |
EBIT Per Share | 6.204 | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 |
EBITDA Per Share | 6.204 | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 |
Free Cash Flow Per Share | 6.077 | 5.903 | 11.752 | 10.499 | 18.021 | 37.989 | 25.339 | 20.246 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 104,1M | 109,48M | 111,09M | 108,43M | 105,1M | 106,85M | 107,8M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 107,8M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 27.703 | N/A | N/A | N/A | 22.792 | N/A | N/A |
Net Profit Margin (%) | N/A | 25.863 | N/A | N/A | N/A | 22.957 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 77,83B |
Ratio cours/bénéfice | 19,51 |
Ratio prix/ventes | 5,88 |
Ratio prix/liquidités | 28,25 |
Ratio prix/valeur comptable | 2,97 |
Rendement de dividende | - |
Actions en circulation | 109,89M |
Volume moyen (1 semaine) | 889,39k |
Volume moyen (1 mois) | 854,43k |
Variation sur 52 semaines | -16,90% |
Plus haut sur 52 semaines | 1 211,1999 |
Plus bas sur 52 semaines | 693,00 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales